All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
APOGEE THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: APGE

Business Address

221 CRESCENT ST.
BUILDING 17, SUITE 102B
WALTHAM , MA US 02453

Mailing Address

221 CRESCENT ST.
BUILDING 17, SUITE 102B
WALTHAM , MA US 02453
Phone Number: 650-394-5230 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 6/30/2023 12/31/2022 9/30/2022 6/30/2022
Cash and Cash Equivalents $485,457,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,412,000.00 $5,598,000.00 $165,000.00 -- --
Total Current Assets $820,608,000.00 $130,667,000.00 $152,055,000.00 -- --
Property Plant and Equipement $699,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- --
Goodwill -- -- -- -- --
Other Assets $401,000.00 -- -- -- --
Total Assets $823,659,000.00 $130,667,000.00 $152,055,000.00 -- --
Accounts Payable $4,302,000.00 $11,148,000.00 $418,000.00 -- --
Accrued Liabilities $16,108,000.00 $6,467,000.00 $9,562,000.00 -- --
Total Current Liabilities $22,181,000.00 $17,615,000.00 $9,980,000.00 -- --
Long Term Debt -- -- -- -- --
Additional Paid-in Capital -- -- -- -- --
Accumulated Other Comprehensive Loss $-177,000.00 -- -- -- --
Accumulated Deficit $-155,900,000.00 $-71,195,000.00 $-39,785,000.00 -- --
Total Stockholders' Equity -- -- -- -- --
Controlling Interest in Subsidiaries -- -- -- -- --
Total Liabilities and Equity $823,659,000.00 $130,667,000.00 $152,055,000.00 -- --

Statement of Operations

Date 3/31/2024 6/30/2023 12/31/2022 9/30/2022 6/30/2022
Total Revenues -- -- -- -- --
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Research and Development $28,716,000.00 $13,946,000.00 -- $9,885,000.00 $1,448,000.00
Selling, General, and Administrative -- -- -- -- --
Total Operating Expenses $38,181,000.00 $31,543,000.00 -- $10,507,000.00 $6,121,000.00
Loss from Operations $-38,181,000.00 $-18,885,000.00 -- $-16,628,000.00 $-1,816,000.00
Loss Before Income Taxes -- -- -- -- --
Earnings Per Share Basic $-0.64 $-6.28 -- $-17.00 $-5.25
Weighted Average Shares Basic 50,189,808 5,000,000 -- 2,078,804 1,250,000
Earnings Per Share Diluted $-0.64 $-3.78 -- $-9.46 $-5.25
Weighted Average Shares Diluted 50,189,808 5,000,000 -- 1,516,736 1,250,000
Common Stock Shares Authorized 400,000,000 -- -- -- --
Common Stock Shares Outstanding 56,367,802 -- -- -- --
Common Stock Value $1,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- --
Preferred Stock Value -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- --
Share Price -- -- -- -- --
Copyright 2024 PursePoor.com